{"id":53133,"date":"2026-02-23T10:16:49","date_gmt":"2026-02-23T10:16:49","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/lipid-nanoparticles-market-mordor\/"},"modified":"2026-09-25T12:54:54","modified_gmt":"2026-09-25T03:54:54","slug":"lipid-nanoparticles-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/lipid-nanoparticles-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/lipid-nanoparticles-market-1713167547060-Key-Players-Chart-Template.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/lipid-nanoparticles-market-size-image-1770985676028.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \ub9cc\uc131 \ubc0f \ud76c\uadc0 \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 COVID-19\ub97c \ub118\uc5b4\uc120 \ud3ed\ubc1c\uc801\uc778 mRNA \ubc31\uc2e0 \ud30c\uc774\ud504\ub77c\uc778<\/li>\n<li class=\"toc-level-3\">4.2.3 \ub300\uaddc\ubaa8 \uc815\ubd80 \ud32c\ub370\ubbf9 \ub300\ube44 \ube44\ucd95<\/li>\n<li class=\"toc-level-3\">4.2.4 APAC \uc9c0\uc5ed CDMO \uc9c0\uc9c8 \ud63c\ud569 \uc5ed\ub7c9 \ud655\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.5 \uc870\uc9c1 \ud45c\uc801\ud654\ub97c \uac00\ub2a5\ud558\uac8c \ud558\ub294 AI \uc124\uacc4 \uc774\uc628\ud654 \uc9c0\uc9c8<\/li>\n<li class=\"toc-level-3\">4.2.6 \ubbf8\uc138\uc720\uccb4 \uae30\ubc18 \uc5f0\uc18d \uc81c\uc870 \ucc44\ud0dd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc5c4\uaca9\ud55c CMC \ubc0f \uba74\uc5ed\uc6d0\uc131 \ub370\uc774\ud130 \uc694\uad6c\uc0ac\ud56d<\/li>\n<li class=\"toc-level-3\">4.3.2 \uace0\uc21c\ub3c4 \uc774\uc628\ud654 \uc9c0\uc9c8 \uac00\uaca9 \ubcc0\ub3d9\uc131<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc6a9\ub9e4 \uc0ac\uc6a9\uc774 \ub9ce\uc740 \uacf5\uc815\uc758 \ud658\uacbd \ubc1c\uc790\uad6d<\/li>\n<li class=\"toc-level-3\">4.3.4 \uae30\uc874 SLN \ud50c\ub7ab\ud3fc\uc758 \uc801\uc7ac \uc6a9\ub7c9 \ud55c\uacc4<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.6 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.6.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc81c\ud488 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uace0\uccb4 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790 (SLN)<\/li>\n<li class=\"toc-level-3\">5.1.2 \ub098\ub178\uad6c\uc870 \uc9c0\uc9c8 \uc6b4\ubc18\uccb4 (NLC)<\/li>\n<li class=\"toc-level-3\">5.1.3 \uae30\ud0c0 \uc720\ud615<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc801\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc5f0\uad6c<\/li>\n<li class=\"toc-level-3\">5.2.2 \uce58\ub8cc\uc81c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ubd84\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 siRNA<\/li>\n<li class=\"toc-level-3\">5.3.2 mRNA<\/li>\n<li class=\"toc-level-3\">5.3.3 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5<\/li>\n<li class=\"toc-level-3\">5.4.2 \uacc4\uc57d \uac1c\ubc1c &amp; \uc81c\uc870 \uc870\uc9c1<\/li>\n<li class=\"toc-level-3\">5.4.3 \ud559\uc220 &amp; \uc5f0\uad6c \uae30\uad00<\/li>\n<li class=\"toc-level-3\">5.4.4 \uae30\ud0c0 \ucd5c\uc885 \uc0ac\uc6a9\uc790<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Merck KGaA<\/li>\n<li class=\"toc-level-3\">6.3.2 Croda International plc (Avanti Polar Lipids)<\/li>\n<li class=\"toc-level-3\">6.3.3 Evonik Industries AG<\/li>\n<li class=\"toc-level-3\">6.3.4 Acuitas Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.5 CordenPharma International<\/li>\n<li class=\"toc-level-3\">6.3.6 BIOVECTRA<\/li>\n<li class=\"toc-level-3\">6.3.7 Genevant Sciences<\/li>\n<li class=\"toc-level-3\">6.3.8 Arcturus Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.9 Ascendia Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.3.10 CD Bioparticles<\/li>\n<li class=\"toc-level-3\">6.3.11 Moderna Inc.<\/li>\n<li class=\"toc-level-3\">6.3.12 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.13 BioNTech SE<\/li>\n<li class=\"toc-level-3\">6.3.14 Danaher (Precision NanoSystems)<\/li>\n<li class=\"toc-level-3\">6.3.15 Gattefoss\u00e9<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc9c0\uc9c8 \ub098\ub178\uc785\uc790(Lipid Nanoparticles, LNP) \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc804\ub9dd (2026-2031)<\/p>\n<p># 1. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5\ub960<\/p>\n<p>\uc9c0\uc9c8 \ub098\ub178\uc785\uc790(Lipid Nanoparticles, LNP) \uc2dc\uc7a5\uc740 2026\ub144 10\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 18\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc608\uce21 \uae30\uac04(2026-2031) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 12.31%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. 2025\ub144 \uc2dc\uc7a5 \uaddc\ubaa8\ub294 9\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \ucd94\uc815\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uacac\uace0\ud55c \uc131\uc7a5\uc740 LNP \uae30\uc220\uc774 \uae34\uae09 \ubc31\uc2e0 \uc6b4\ubc18\uccb4\uc5d0\uc11c \uc720\uc804\uc790 \uce58\ub8cc, \uc554 \uba74\uc5ed \uce58\ub8cc, \ud76c\uadc0 \uc9c8\ud658 \uce58\ub8cc\ub97c \uc704\ud55c \ub2e4\ubaa9\uc801 \uc6b4\ubc18\uccb4\ub85c \uc9c4\ud654\ud558\uace0 \uc788\uc74c\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. \uc0dd\uccb4 \ub0b4 CAR T \uc138\ud3ec \ud504\ub85c\uadf8\ub798\ubc0d, \uc131\uacf5\uc801\uc778 \uac04\uc678 \uc870\uc9c1 \ud45c\uc801 \uc804\ub2ec\uc5d0 \ub300\ud55c \uac15\ub825\ud55c \uc784\uc0c1 \ub370\uc774\ud130, \uadf8\ub9ac\uace0 \uc5f0\uc18d \uc81c\uc870 \uc0dd\uc0b0\uc131 \ud5a5\uc0c1\uc740 \uc9c0\uc18d\uc801\uc778 \ubca4\ucc98 \ubc0f \uc804\ub7b5\uc801 \ud22c\uc790\ub97c \uc720\uce58\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, FDA\uc758 2024\ub144 \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \uae30\ubc18 \uc81c\ud488\uc5d0 \ub300\ud55c \ube44\uc784\uc0c1 \uae30\ub300\uce58\ub97c \uba85\ud655\ud788 \ud558\ub294 \uc9c0\uce68\uc740 \ucc28\uc138\ub300 \uc81c\ud615\uc758 \uc2b9\uc778 \ubd88\ud655\uc2e4\uc131\uc744 \uc904\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \ub354\uc6b1 \ubc15\ucc28\ub97c \uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc744 \uc911\uc2ec\uc73c\ub85c \uae00\ub85c\ubc8c CDMO(Contract Development &#038; Manufacturing Organizations)\uc758 \uc0dd\uc0b0 \ub2a5\ub825 \uc99d\uac00\ub294 \ud30c\uc774\ud504\ub77c\uc778 \uc218\uc694\uc640 \uc81c\uc870 \ucc98\ub9ac\ub7c9\uc744 \uc77c\uce58\uc2dc\ud0a4\uace0 \uc788\uc73c\uba70, AI(\uc778\uacf5\uc9c0\ub2a5)\ub85c \uc124\uacc4\ub41c \uc774\uc628\ud654 \uc9c0\uc9c8\uc740 \ub2e4\uc591\ud55c \uc870\uc9c1 \uc720\ud615\uc5d0 \uac78\uccd0 \uce58\ub8cc \ubc94\uc704\ub97c \ud655\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 2. \ud575\uc2ec \uc2dc\uc7a5 \uc694\uc57d<\/p>\n<p>*   \uc5f0\uad6c \uae30\uac04: 2020\ub144 &#8211; 2031\ub144<br \/>\n*   2026\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 10\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   2031\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 18\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   \uc131\uc7a5\ub960 (2026-2031): 12.31% CAGR<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \ubd81\ubbf8<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04<\/p>\n<p># 3. \uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>*   \uc81c\ud488 \uc720\ud615\ubcc4: 2025\ub144 \uace0\uccb4 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(Solid Lipid Nanoparticles, SLN)\uac00 71.20%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\ub85c \uc6b0\uc704\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \ub098\ub178\uad6c\uc870 \uc9c0\uc9c8 \uc6b4\ubc18\uccb4(Nanostructured Lipid Carriers, NLC)\ub294 2031\ub144\uae4c\uc9c0 13.04%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc801\uc6a9 \ubd84\uc57c\ubcc4: 2025\ub144 \uce58\ub8cc\uc6a9(Therapeutics)\uc774 LNP \uc2dc\uc7a5\uc758 59.60%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc5f0\uad6c\uc6a9(Research)\uc740 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 13.12%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ubd84\uc790 \uc720\ud615\ubcc4: 2025\ub144 mRNA\uac00 LNP \uc2dc\uc7a5\uc758 54.60%\ub97c \uc810\uc720\ud588\uc73c\uba70, siRNA \ubd84\uc790\ub294 2031\ub144\uae4c\uc9c0 11.35%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: 2025\ub144 \ubd81\ubbf8\uac00 37.90%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\ub85c \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc774\uc5c8\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 13.78%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p># 4. \uae00\ub85c\ubc8c \uc9c0\uc9c8 \ub098\ub178\uc785\uc790 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p> 4.1. \uc131\uc7a5 \ub3d9\ub825 (Drivers)<\/p>\n<p>*   \ub9cc\uc131 \ubc0f \ud76c\uadc0 \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00 (+2.1% CAGR \uc601\ud5a5): \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc554, \ub300\uc0ac\uc131 \uc9c8\ud658, \uc2e0\uacbd\ud559\uc801 \uc9c8\ud658\uc758 \ubd80\ub2f4\uc774 \uc99d\uac00\ud558\uba74\uc11c \uc0dd\ub9ac\uc801 \uc7a5\ubcbd\uc744 \uc6b0\ud68c\ud558\ub294 \uc815\ubc00 \uc804\ub2ec \ud50c\ub7ab\ud3fc\uc5d0 \ub300\ud55c \uc9c0\uc18d\uc801\uc778 \uc218\uc694\uac00 \ubc1c\uc0dd\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. LNP \uae30\ubc18 \uc554 \ubc31\uc2e0(\uc608: mRNA-4157)\uc740 \uc885\uc591 \uc7ac\ubc1c\uc744 44% \uac10\uc18c\uc2dc\ud0a4\ub294 \ub4f1 \uc784\uc0c1\uc801 \uc131\uacf5\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc7a5\uae30\uc801\uc778 \uc2dc\uc7a5 \uc218\uc694\ub97c \uacac\uc778\ud560 \uc8fc\uc694 \uc694\uc778\uc785\ub2c8\ub2e4.<br \/>\n*   COVID-19 \uc774\ud6c4 mRNA \ubc31\uc2e0 \ud30c\uc774\ud504\ub77c\uc778\uc758 \ud3ed\ubc1c\uc801 \ud655\uc7a5 (+2.3% CAGR \uc601\ud5a5): COVID-19 \ud32c\ub370\ubbf9\uc740 mRNA \uae30\uc220\uc758 \uc720\ud6a8\uc131\uc744 \uc785\uc99d\ud558\uace0 \uac1c\ubc1c \uae30\uac04\uc744 \ub2e8\ucd95\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \uc778\ud50c\ub8e8\uc5d4\uc790, RSV, \uac70\ub300\uc138\ud3ec\ubc14\uc774\ub7ec\uc2a4 \ubc0f \ub2e4\uc591\ud55c \uc554 \ud56d\uc6d0\uc5d0 \ub300\ud55c \uc608\ubc29 \ubc0f \uce58\ub8cc\uc6a9 mRNA \ubc31\uc2e0 \uac1c\ubc1c\uc774 \ud65c\ubc1c\ud558\uba70, 2029\ub144 \uc774\uc804\uc5d0 \ube44-COVID mRNA \ubc31\uc2e0\uc758 \uc0c1\uc5c5\uc801 \uc2b9\uc778\uc774 \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc815\ubd80\uc758 \ub300\uaddc\ubaa8 \ud32c\ub370\ubbf9 \ub300\ube44 \ube44\ucd95 (+1.8% CAGR \uc601\ud5a5): BARDA\uc640 \uac19\uc740 \uae30\uad00\ub4e4\uc740 \uad6d\ub0b4 \ud65c\uc131 \uc758\uc57d\ud488 \uc131\ubd84 \ubc0f \uc644\uc81c \ubc31\uc2e0 \ube44\ucd95\uc744 \uc9c0\uc6d0\ud558\uc5ec \uacf5\uae09 \ubd80\uc871\uc744 \ubc29\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc774\uc628\ud654 \uc9c0\uc9c8, \ud63c\ud569 \uc7a5\ube44 \ub4f1\uc5d0 \ub300\ud55c \ud22c\uc790\ub97c \uc720\ub3c4\ud558\uc5ec \ubbfc\uac04 \uc0dd\uc0b0 \ub2a5\ub825 \ud655\uc7a5\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed CDMO\uc758 \uc9c0\uc9c8 \ud63c\ud569 \uc0dd\uc0b0 \ub2a5\ub825 \ud655\uc7a5 (+2.0% CAGR \uc601\ud5a5): \uc2f1\uac00\ud3ec\ub974, \ud55c\uad6d, \uc778\ub3c4 \ub4f1 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc758 \uacc4\uc57d \uac1c\ubc1c \ubc0f \uc81c\uc870 \uc870\uc9c1(CDMO)\ub4e4\uc740 \ub9c8\uc774\ud06c\ub85c\uc720\uccb4 \ub77c\uc778\uc744 \ucd94\uac00\ud558\uc5ec LNP \uc870\ub9bd\uc744 \uc704\ud55c \uc0dd\uc0b0 \ub2a5\ub825\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc11c\uad6c \ubc14\uc774\uc624 \uc81c\uc57d \uace0\uac1d\ub4e4\uc5d0\uac8c \ub2e4\uc591\ud55c \uacf5\uae09\ub9dd \uc635\uc158\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   AI \uc124\uacc4 \uc774\uc628\ud654 \uc9c0\uc9c8\uc744 \ud1b5\ud55c \uc870\uc9c1 \ud45c\uc801\ud654 (+2.4% CAGR \uc601\ud5a5): \uc778\uacf5\uc9c0\ub2a5(AI)\uc744 \ud65c\uc6a9\ud55c \uc774\uc628\ud654 \uc9c0\uc9c8 \uc124\uacc4\ub294 \ub9de\ucda4\ud615 pKa \uac12, \uc0dd\ubd84\ud574\uc131 \ubc0f \uc870\uc9c1 \ud2b9\uc774\uc131\uc744 \uac00\uc9c4 \uc9c0\uc9c8 \ubc1c\uacac\uc744 \uac00\uc18d\ud654\ud558\uc5ec \ub2e4\uc591\ud55c \uc870\uc9c1 \uc720\ud615\uc5d0 \uac78\uccd0 \uce58\ub8cc \ubc94\uc704\ub97c \ud655\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 LNP \uae30\uc220\uc758 \uc801\uc6a9 \uac00\ub2a5\uc131\uc744 \ud06c\uac8c \ub192\uc774\ub294 \uc7a5\uae30\uc801\uc778 \uc131\uc7a5 \ub3d9\ub825\uc785\ub2c8\ub2e4.<br \/>\n*   \ub9c8\uc774\ud06c\ub85c\uc720\uccb4 \uae30\ubc18 \uc5f0\uc18d \uc81c\uc870 (+1.9% CAGR \uc601\ud5a5): \ub9c8\uc774\ud06c\ub85c\uc720\uccb4 \uae30\uc220\uc744 \ud65c\uc6a9\ud55c \uc5f0\uc18d \uc81c\uc870 \ubc29\uc2dd\uc740 \uc0dd\uc0b0 \ud6a8\uc728\uc131\uc744 \ub192\uc774\uace0 \uc77c\uad00\ub41c LNP \uc785\uc790 \ud06c\uae30 \ubd84\ud3ec\ub97c \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 4.2. \uc81c\uc57d \uc694\uc778 (Restraints)<\/p>\n<p>*   \uc5c4\uaca9\ud55c CMC(\ud654\ud559, \uc81c\uc870 \ubc0f \uad00\ub9ac) \ubc0f \uba74\uc5ed\uc6d0\uc131 \ub370\uc774\ud130 \uc694\uad6c\uc0ac\ud56d (-2.1% CAGR \uc601\ud5a5): \ube44\uc0c1 \uc2b9\uc778 \uacbd\ub85c \uc774\ud6c4\uc5d0\ub294 \uc7a5\uae30 \uba74\uc5ed\uc6d0\uc131 \ubaa8\ub2c8\ud130\ub9c1, \uc870\uc9c1 \ubcd1\ub9ac \uac80\uc0ac, \ube44\ud45c\uc801 \uc0dd\uccb4 \ubd84\ud3ec \uc5f0\uad6c\ub97c \ud3ec\ud568\ud55c \uc644\uc804\ud55c CMC \ud328\ud0a4\uc9c0\uac00 \uc694\uad6c\ub429\ub2c8\ub2e4. FDA\uc758 \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c 2024\ub144 \ucd08\uc548 \uc9c0\uce68\uc740 \uad11\ubc94\uc704\ud55c \ub3c5\uc131 \ud3c9\uac00\ub97c \uba85\uc2dc\ud558\uc5ec \uac1c\ubc1c \uae30\uac04\uacfc \ube44\uc6a9\uc744 \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   \uace0\uc21c\ub3c4 \uc774\uc628\ud654 \uc9c0\uc9c8 \uac00\uaca9 \ubcc0\ub3d9\uc131 (-1.7% CAGR \uc601\ud5a5): \uc18c\uc218\uc758 \uacf5\uae09\uc5c5\uccb4\uac00 \uc81c\uc57d \ub4f1\uae09 \uc774\uc628\ud654 \uc9c0\uc9c8 \uc0dd\uc0b0\uc758 \ub300\ubd80\ubd84\uc744 \ud1b5\uc81c\ud558\uace0 \uc788\uc5b4, \ud32c\ub370\ubbf9 \uae30\uac04 \ub3d9\uc548 \uac00\uaca9\uc774 \uae09\ub4f1\ud558\ub294 \ub4f1 \ubcc0\ub3d9\uc131\uc774 \ud07d\ub2c8\ub2e4. \uc774\ub294 \ub2e8\uae30\uc801\uc778 \ub9c8\uc9c4 \uc555\ubc15\uc744 \uc57c\uae30\ud558\uba70, \uacf5\uae09\ub9dd \ub2e4\ubcc0\ud654 \ubc0f \uc218\uc9c1 \ud1b5\ud569 \uc804\ub7b5\uc744 \uc720\ub3c4\ud569\ub2c8\ub2e4.<br \/>\n*   \uc6a9\ub9e4 \uae30\ubc18 \uacf5\uc815\uc758 \ud658\uacbd \ubc1c\uc790\uad6d (-1.5% CAGR \uc601\ud5a5): \uc6a9\ub9e4\ub97c \ub9ce\uc774 \uc0ac\uc6a9\ud558\ub294 LNP \uc81c\uc870 \uacf5\uc815\uc740 \ud658\uacbd\uc801 \uc601\ud5a5\uc744 \ubbf8\uce58\uba70, \ud2b9\ud788 \uc720\ub7fd\uc744 \uc911\uc2ec\uc73c\ub85c \ud658\uacbd \uaddc\uc81c\uac00 \uac15\ud654\ub418\uba74\uc11c \uce5c\ud658\uacbd \uc0dd\uc0b0 \uae30\uc220 \uac1c\ubc1c\uc758 \ud544\uc694\uc131\uc774 \ucee4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uae30\uc874 SLN \ud50c\ub7ab\ud3fc\uc758 \uc801\uc7ac \uc6a9\ub7c9 \ud55c\uacc4 (-1.9% CAGR \uc601\ud5a5): \uae30\uc874 \uace0\uccb4 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(SLN) \ud50c\ub7ab\ud3fc\uc740 \uc57d\ubb3c \uc801\uc7ac \uc6a9\ub7c9\uc5d0 \ud55c\uacc4\uac00 \uc788\uc5b4, \uace0\uc6a9\ub7c9 \uc57d\ubb3c \uc804\ub2ec\uc774 \ud544\uc694\ud55c \uce58\ub8cc \ubd84\uc57c\uc5d0\uc11c\ub294 \uc81c\uc57d\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p># 5. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p> 5.1. \uc81c\ud488 \uc720\ud615\ubcc4: SLN\uc758 \uc9c0\ubc30\ub825\uacfc NLC\uc758 \ud601\uc2e0<\/p>\n<p>\uace0\uccb4 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(SLN)\ub294 \uac80\uc99d\ub41c \uc81c\uc870 \ub178\ud558\uc6b0\uc640 \uae30\uc874 \ucda9\uc804 \ub77c\uc778 \uae30\ubc18\uc73c\ub85c 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 71.20%\ub97c \ucc28\uc9c0\ud558\uba70 \uc5ec\uc804\ud788 \uc9c0\ubc30\uc801\uc785\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ub098\ub178\uad6c\uc870 \uc9c0\uc9c8 \uc6b4\ubc18\uccb4(NLC)\ub294 2031\ub144\uae4c\uc9c0 13.04%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc774\uba70 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. NLC\ub294 \ub354 \ub192\uc740 \uc57d\ubb3c \uc801\uc7ac \uc6a9\ub7c9\uacfc \ud5a5\uc0c1\ub41c \ucf5c\ub85c\uc774\ub4dc \uc548\uc815\uc131\uc744 \uc81c\uacf5\ud558\uc5ec \ub0ae\uc740 \ud22c\uc5ec\ub7c9\uacfc \uc5f0\uc7a5\ub41c \uc720\ud6a8 \uae30\uac04\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4. \uc554 \uce58\ub8cc \ud504\ub85c\uadf8\ub7a8\uc5d0\uc11c \uc694\uad6c\ub418\ub294 \uc6a9\ub7c9\uc774 \uc99d\uac00\ud568\uc5d0 \ub530\ub77c NLC \uc81c\ud615\uc774 \ub192\uc740 \uc6d0\uc790\uc7ac \ube44\uc6a9\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \ub9e4\ub825\uc801\uc73c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uc2dc\uc7a5 \uc218\uc775 \uad6c\uc131\uc774 SLN\uc5d0\uc11c NLC\ub85c \uc810\uc9c4\uc801\uc73c\ub85c \uc804\ud658\ub420 \uac83\uc784\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4. \ub9c8\uc774\ud06c\ub85c\uc720\uccb4 \uae30\ubc18 \uc5f0\uc18d \uc81c\uc870\uc640 \uac19\uc740 \uacf5\uc815 \ud601\uc2e0\uc740 NLC\uc758 \ube44\uc6a9 \uaca9\ucc28\ub97c \uc904\uc774\uace0 \uc788\uc73c\uba70, \uace0\uccb4 \ubc0f \uc561\uccb4 \uc9c0\uc9c8\uc744 \ud63c\ud569\ud55c \ud558\uc774\ube0c\ub9ac\ub4dc \uad6c\uc870\uc640 \uc561\uc815 \ub098\ub178\uc785\uc790(LCNP)\ub3c4 \uc5f0\uad6c\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 5.2. \uc801\uc6a9 \ubd84\uc57c\ubcc4: \uce58\ub8cc\uc6a9\uc758 \uc120\ub450 \uc720\uc9c0 \ubc0f \uc5f0\uad6c\uc6a9\uc758 \uac00\uc18d\ud654<\/p>\n<p>\uce58\ub8cc\uc6a9\uc740 2025\ub144 \ub9e4\ucd9c\uc758 59.60%\ub97c \ucc28\uc9c0\ud558\uba70 \uc5ec\ub7ec \ud6c4\uae30 \uc784\uc0c1 \ud504\ub85c\uadf8\ub7a8\uc5d0 \ud798\uc785\uc5b4 \uc8fc\uc694 \ud22c\uc790 \ub3d9\ub825\uc73c\ub85c \ub0a8\uc544\uc788\uc2b5\ub2c8\ub2e4. \uc554, \uac10\uc5fc\ubcd1, \uc2ec\uc7a5\ubcd1 \ubd84\uc57c\uac00 \ub2e8\uae30\uc801\uc778 \uc0c1\uc5c5\uc801 \ubb3c\ub7c9\uc744 \uacac\uc778\ud569\ub2c8\ub2e4. \ud55c\ud3b8, \uc5f0\uad6c\uc6a9 \uc801\uc6a9 \ubd84\uc57c\ub294 \ud45c\uc900\ud654\ub41c \ub098\ub178\uc785\uc790 \ud0a4\ud2b8\uc758 \ubcf4\uae09\uc73c\ub85c \uc778\ud574 2031\ub144\uae4c\uc9c0 \uc5f0\uac04 13.12% \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. LNP \uc2dc\uc7a5\uc740 \uc5f0\uad6c \uc9c0\ucd9c\uc774 \uc0c8\ub85c\uc6b4 \uc801\uc751\uc99d\uc744 \ubc1c\uad74\ud558\uace0, \uc784\uc0c1\uc801 \uc99d\uba85\uc774 \ubca4\ucc98 \uc790\ubcf8\uc744 \uc911\uac1c \uc5f0\uad6c \ud504\ub85c\uc81d\ud2b8\ub85c \uc7ac\ud560\ub2f9\ud558\ub294 \uc120\uc21c\ud658 \uad6c\uc870\uc758 \ud61c\ud0dd\uc744 \ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud559\uc220 \uc5f0\uad6c \uc218\uc694\ub294 \uac04\uc678 \uc804\ub2ec(\ud3d0 \ubc0f \uc548\uad6c \ud45c\uc801 \ud3ec\ud568) \ud0d0\uc0c9\uc744 \uc704\ud55c \ubcf4\uc870\uae08 \uc9c0\uc6d0\uc73c\ub85c \uae09\uc99d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 5.3. \ubd84\uc790 \uc720\ud615\ubcc4: mRNA\uc758 \uc9c0\ubc30\ub825\uacfc siRNA\uc758 \uc131\uc7a5<\/p>\n<p>mRNA\ub294 \ud32c\ub370\ubbf9 \ubc31\uc2e0 \ub9e4\ucd9c\uacfc \uc554 \ubc31\uc2e0 \uc784\uc0c1 \uc2dc\ud5d8 \ud655\ub300\ub85c \uc778\ud574 2025\ub144 LNP \uc2dc\uc7a5\uc758 54.60%\ub97c \uc810\uc720\ud588\uc2b5\ub2c8\ub2e4. 2020-2023\ub144\uc758 \uc608\uc678\uc801\uc778 \uc131\uc7a5\uc138\ub294 \uc644\ud654\ub418\uaca0\uc9c0\ub9cc, \uc554 \ubc0f \uac10\uc5fc\ubcd1 \ud30c\uc774\ud504\ub77c\uc778\uc740 \ub2e8\uc704 \ubb3c\ub7c9\uc744 \ub192\uac8c \uc720\uc9c0\ud560 \uac83\uc785\ub2c8\ub2e4. siRNA\ub294 \uc2ec\ud608\uad00 \uc9c8\ud658 \uce58\ub8cc\uc81c(\uc608: \uc9c0\ub2e8\ubc31(a)\ub97c \ud45c\uc801\uc73c\ub85c \ud558\ub294 \ub808\ud3ec\ub514\uc2dc\ub780)\uc640 \uac19\uc740 \ud6c4\ubcf4 \ubb3c\uc9c8\uc5d0 \ud798\uc785\uc5b4 11.35%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. DNA \ud50c\ub77c\uc2a4\ubbf8\ub4dc \ubc0f CRISPR \uad6c\uc131 \uc694\uc18c\ub294 \uc544\uc9c1 \ud2c8\uc0c8\uc2dc\uc7a5\uc774\uc9c0\ub9cc, \ud3b8\uc9d1 \ud2b9\uc774\uc131 \ubb38\uc81c\uac00 \ud574\uacb0\ub418\uba74 \uc131\uc7a5 \uc7a0\uc7ac\ub825\uc774 \ud07d\ub2c8\ub2e4. LNP \uc0b0\uc5c5\uc740 \ub2e4\uc591\ud55c \ud575\uc0b0 \ud074\ub798\uc2a4\uac00 \uacf5\uc874\ud558\uba70 \uac01\uac01 \ub9de\ucda4\ud615 \uc9c0\uc9c8 \ud654\ud559\uc744 \uc694\uad6c\ud558\ub294 \ub2e4\uac01\ud654\ub41c \uc2dc\uc7a5\uc744 \uae30\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 5.4. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uc81c\uc57d\uc0ac\uc758 \uc120\ub450 \uc720\uc9c0 \ubc0f \ud559\uacc4\uc758 \ud601\uc2e0 \uc8fc\ub3c4<\/p>\n<p>\uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5\uc740 2025\ub144 \ub9e4\ucd9c\uc758 57.80%\ub97c \ucc28\uc9c0\ud558\uba70, \ub0b4\ubd80 GMP \uc2dc\uc124\uc744 \ud65c\uc6a9\ud558\uac70\ub098 \uc0c1\uc5c5\uc801 \uc0dd\uc0b0\uc744 \uc704\ud574 \uc804\ubb38 CDMO\uc5d0 \uc544\uc6c3\uc18c\uc2f1\ud569\ub2c8\ub2e4. \uc774\ub4e4\uc740 \uaddc\uc81c \uc900\uc218, \uaddc\ubaa8 \ud655\uc7a5 \ubc0f \uc81c\ud488 \uc218\uba85 \uc8fc\uae30 \uad00\ub9ac\uc5d0 \uc911\uc810\uc744 \ub461\ub2c8\ub2e4. \ud559\uacc4 \ubc0f \uc5f0\uad6c \uae30\uad00\uc740 \ubcf4\uc870\uae08 \ud560\ub2f9 \uc99d\uac00\uc640 \ud0a4\ud2b8 \uae30\ubc18 \uc194\ub8e8\uc158\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 13.52%\uc758 \uac00\uc7a5 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774 \uadf8\ub8f9\uc740 \ucd08\uae30 \ub2e8\uacc4 \uac00\uc124 \uac80\uc99d\uc744 \uc8fc\ub3c4\ud558\uace0 Capstan Therapeutics\uac00 \uac1c\ucc99\ud55c \uc0dd\uccb4 \ub0b4 CAR T \uc138\ud3ec \uc7ac\ud504\ub85c\uadf8\ub798\ubc0d\uacfc \uac19\uc740 \uc0c8\ub85c\uc6b4 \uc804\ub2ec \ud328\ub7ec\ub2e4\uc784\uc744 \ubc1c\uad74\ud569\ub2c8\ub2e4. CDMO\ub294 \ucd08\uae30 \ub2e8\uacc4 \ubc1c\uba85\uac00\uc640 \ub300\ud615 \uc81c\uc57d\uc0ac \ubaa8\ub450\uc5d0\uac8c \uc81c\ud615 \uc2a4\ud06c\ub9ac\ub2dd, \ubd84\uc11d \ud2b9\uc131 \ubd84\uc11d \ubc0f \ucda9\uc804-\uc644\uc131 \uc9c0\uc6d0\uc744 \uc81c\uacf5\ud558\ub294 \uac00\uad50 \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4. Danaher\uc758 Precision NanoSystems \uc778\uc218\ub294 \ud50c\ub7ab\ud3fc \uc5ed\ub7c9 \ud655\ubcf4\uc5d0 \ub300\ud55c \uc804\ub7b5\uc801 \uad00\uc2ec\uc744 \ubcf4\uc5ec\uc8fc\uba70, \uc11c\ube44\uc2a4 \uc81c\uacf5\uc5c5\uccb4 \uac04\uc758 \ucd94\uac00\uc801\uc778 \ud1b5\ud569\uc744 \uc608\uace0\ud569\ub2c8\ub2e4.<\/p>\n<p># 6. \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \ub9e4\ucd9c\uc758 37.90%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \uc9c0\uc5ed \uc2dc\uc7a5\uc785\ub2c8\ub2e4. \uc131\uc219\ud55c \ubc14\uc774\uc624 \uc81c\uc57d \uc778\ud504\ub77c, \ud48d\ubd80\ud55c \ubca4\ucc98 \uc790\uae08, \uba85\ud655\ud55c \uaddc\uc81c \uc120\ub840\uac00 \uac15\uc810\uc785\ub2c8\ub2e4. \ubbf8\uad6d\uc740 \uc554 \ubc0f \ud76c\uadc0 \uc9c8\ud658 \ud504\ub85c\uadf8\ub7a8 \ud30c\uc774\ud504\ub77c\uc778\uc774 \uacac\uace0\ud558\uba70, BARDA\uc758 \uc804\ub7b5\uc801 \ube44\ucd95\uc740 \uae30\ubcf8 \uc218\uc694\ub97c \ubcf4\uc7a5\ud569\ub2c8\ub2e4. \uce90\ub098\ub2e4\ub294 \uc804\ub7b5\uc801 \ud601\uc2e0 \uae30\uae08\uacfc \uac19\uc740 \uc815\ucc45 \uc778\uc13c\ud2f0\ube0c\ub97c \ud1b5\ud574 \uad6d\ub0b4 mRNA \ubc31\uc2e0 \uc2dc\uc124\uc744 \uc9c0\uc6d0\ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \ub450 \ubc88\uc9f8\ub85c \ud070 \uc2dc\uc7a5\uc73c\ub85c, \ub3c5\uc77c\uacfc \uc601\uad6d\uc758 \uc81c\uc870 \ud655\uc7a5\uc73c\ub85c \ub4b7\ubc1b\uce68\ub429\ub2c8\ub2e4. \uc720\ub7fd \uc758\uc57d\ud488\uccad(EMA)\uc740 FDA \uc9c0\uce68\uacfc \uc870\ud654\ub97c \uc774\ub8e8\uba74\uc11c\ub3c4 \ucd94\uac00\uc801\uc778 \ud658\uacbd \ubc0f \uc6a9\ub9e4 \ubc30\ucd9c \uc694\uad6c\uc0ac\ud56d\uc744 \ubd80\uacfc\ud558\uc5ec \uce5c\ud658\uacbd \uc0dd\uc0b0 \uae30\uc220 \uac1c\ubc1c\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4. \ud504\ub791\uc2a4\uc758 Grand-Est \uc9c0\uc5ed\uc740 LNP \uc5f0\uad6c\uc5d0 \ub300\ud55c \uc138\uae08 \uacf5\uc81c\ub97c \uc81c\uacf5\ud558\uc5ec \uc2a4\ud0c0\ud2b8\uc5c5\uacfc \ub2e4\uad6d\uc801 R&#038;D \uc13c\ud130\ub97c \uc720\uce58\ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 13.78%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc785\ub2c8\ub2e4. \uacf5\uaca9\uc801\uc778 CDMO \uc0dd\uc0b0 \ub2a5\ub825 \ud655\ucda9, \uacbd\uc7c1\ub825 \uc788\ub294 \uac00\uaca9, \uc815\ubd80 \uc9c0\uc6d0 \uc790\uae08\uc774 \uc131\uc7a5\uc744 \uacac\uc778\ud569\ub2c8\ub2e4. \uc2f1\uac00\ud3ec\ub974\uc758 Tuas \ubc14\uc774\uc624\uba54\ub514\uceec \ud5c8\ube0c\ub294 \uc784\uc0c1 \ubc0f \uc0c1\uc5c5\uc801 \uc0dd\uc0b0 \uc18d\ub3c4\ub97c \ubaa8\ub450 \ucc98\ub9ac\ud560 \uc218 \uc788\ub294 \uc5f0\uc18d \uc81c\uc870 \ub77c\uc778\uc744 \uac16\ucd94\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud55c\uad6d\uc758 \ubc14\uc774\uc624\ucf54\ub9ac\uc544 \uc815\ucc45\uc740 \uc7a5\ube44 \uc218\uc785\uc5d0 \ub300\ud55c \uc138\uae08 \uac10\uba74\uc744 \uc81c\uacf5\ud558\uba70, \uc77c\ubcf8\uc758 \uc758\uc57d\ud488\uc758\ub8cc\uae30\uae30\uc885\ud569\uae30\uad6c(PMDA)\ub294 \ud575\uc0b0 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uc6b0\uc120 \uc2ec\uc0ac\ub97c \uac04\uc18c\ud654\ud569\ub2c8\ub2e4. \uc911\uad6d\uc740 \uc81c\ub124\ub9ad mRNA \ubc31\uc2e0\uc5d0 \uc911\uc810\uc744 \ub450\uc9c0\ub9cc, \uc9c0\uc801 \uc7ac\uc0b0\uad8c \ubd88\ud655\uc2e4\uc131\uc73c\ub85c \uc778\ud574 \uc11c\uad6c\uc758 \uc544\uc6c3\uc18c\uc2f1\uc5d0\ub294 \uc81c\uc57d\uc774 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8: \uc544\uc9c1 \ucd08\uae30 \ub2e8\uacc4\uc774\uba70, \ud32c\ub370\ubbf9 \ub300\ube44 \uae30\uc220 \uc774\uc804 \ud611\uc57d \ubc0f \uc0b0\ubc1c\uc801\uc778 \ud559\uc220 \ud504\ub85c\uadf8\ub7a8\uc5d0 \uc911\uc810\uc744 \ub461\ub2c8\ub2e4. \uc758\ub8cc \uc608\uc0b0 \ubc0f \ubc14\uc774\uc624 \uc81c\uc870 \uc815\ucc45\uc774 \uc131\uc219\ud568\uc5d0 \ub530\ub77c \ubbf8\ub798 \ud655\uc7a5 \uac00\ub2a5\uc131\uc774 \uc788\ub294 \uc9c0\uc5ed\uc785\ub2c8\ub2e4.<\/p>\n<p># 7. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc9c0\uc9c8 \ub098\ub178\uc785\uc790 \uc2dc\uc7a5\uc740 \ubc31\uc2e0 \uac15\uc790, \uc804\ubb38 \uc81c\ud615 \uacf5\uae09\uc5c5\uccb4, \ud601\uc2e0\uc801\uc778 \uc2a4\ud0c0\ud2b8\uc5c5\uc774 \ud63c\ud569\ub41c \uc911\uac04 \uc815\ub3c4\uc758 \ud30c\ud3b8\ud654\ub41c \uc2dc\uc7a5\uc785\ub2c8\ub2e4. Acuitas Therapeutics\ub294 GenVoy \uae30\uc220\uc744 \uc5ec\ub7ec \ud611\ub825\uc0ac\uc5d0 \ub77c\uc774\uc120\uc2a4\ud558\uc5ec \uad11\ubc94\uc704\ud55c \ud50c\ub7ab\ud3fc \ucc44\ud0dd\uc744 \uc9c0\uc6d0\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc9c8 \ub098\ub178\uc785\uc790(LNP) \uc2dc\uc7a5 \ubcf4\uace0\uc11c\ub294 \uc758\ub8cc \uc5f0\uad6c \ubc0f \uc57d\ub9ac\ud559 \ubd84\uc57c\uc5d0\uc11c \uad11\ubc94\uc704\ud558\uac8c \ud65c\uc6a9\ub418\ub294 \uace0\ub3c4\ub85c \uc801\uc751\uc131 \uc788\ub294 \ub098\ub178 \uc6b4\ubc18\uccb4\uc778 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790\uc5d0 \ub300\ud55c \uc2ec\uce35 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc9c0\uc9c8 \ub098\ub178\uc785\uc790\ub294 \uc18c\ubd84\uc790, \ud575\uc0b0, \ub2e8\uc77c\ud074\ub860\ud56d\uccb4 \ub4f1 \ub2e4\uc591\ud55c \uce58\ub8cc\uc81c\ub97c \ucea1\uc290\ud654\ud558\uc5ec \uc804\ud1b5\uc801\uc778 \uce58\ub8cc\uc81c\uc758 \ub0ae\uc740 \ud6a8\ub2a5, \ud6a8\uc18c \ubd84\ud574 \ucde8\uc57d\uc131, \ub0ae\uc740 \uc0dd\uccb4 \uc774\uc6a9\ub960, \ube44\ud45c\uc801 \ubd80\uc791\uc6a9 \ub4f1\uc758 \ud55c\uacc4\ub97c \uadf9\ubcf5\ud560 \uc7a0\uc7ac\ub825\uc744 \uc9c0\ub2d9\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \uc2dc\uc7a5\uc740 2026\ub144 10\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 18\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc131\uc7a5\uc758 \uc8fc\uc694 \ub3d9\ub825\uc73c\ub85c\ub294 \ub9cc\uc131 \ubc0f \ud76c\uadc0 \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00, COVID-19\ub97c \ub118\uc5b4\uc120 mRNA \ubc31\uc2e0 \ud30c\uc774\ud504\ub77c\uc778\uc758 \ud3ed\ubc1c\uc801 \ud655\uc7a5, \uc815\ubd80\uc758 \ub300\uaddc\ubaa8 \ud32c\ub370\ubbf9 \ub300\ube44 \ube44\ucd95\ub7c9 \uc99d\uac00, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed CDMO(\uc704\ud0c1 \uac1c\ubc1c \ubc0f \uc81c\uc870 \uc870\uc9c1)\uc758 \uc9c0\uc9c8 \ud63c\ud569 \uc5ed\ub7c9 \ud655\ub300, \uc778\uacf5\uc9c0\ub2a5(AI) \uae30\ubc18 \uc774\uc628\ud654 \uc9c0\uc9c8 \uc124\uacc4 \uae30\uc220\uc744 \ud1b5\ud55c \uc870\uc9c1 \ud45c\uc801\ud654 \uac00\ub2a5\uc131, \uadf8\ub9ac\uace0 \ub9c8\uc774\ud06c\ub85c \uc720\uccb4 \uae30\ubc18 \uc5f0\uc18d \uc81c\uc870 \ubc29\uc2dd\uc758 \ub3c4\uc785 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \uc5c4\uaca9\ud55c CMC(\ud654\ud559, \uc81c\uc870 \ubc0f \uad00\ub9ac) \ubc0f \uba74\uc5ed\uc6d0\uc131 \ub370\uc774\ud130 \uc694\uad6c\uc0ac\ud56d, \uace0\uc21c\ub3c4 \uc774\uc628\ud654 \uc9c0\uc9c8 \uac00\uaca9\uc758 \ubcc0\ub3d9\uc131, \uc6a9\ub9e4 \uc0ac\uc6a9\ub7c9\uc774 \ub9ce\uc740 \uacf5\uc815\uc758 \ud658\uacbd \ubc1c\uc790\uad6d, \uadf8\ub9ac\uace0 \uae30\uc874 \uace0\uccb4 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(SLN) \ud50c\ub7ab\ud3fc\uc758 \uc801\uc7ac \uc6a9\ub7c9 \ud55c\uacc4 \ub4f1\uc774 \uc9c0\uc801\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc81c\ud488 \uc720\ud615\ubcc4\ub85c\ub294 \uace0\uccb4 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(SLN)\uac00 2025\ub144 71.20%\uc758 \uc810\uc720\uc728\ub85c \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud558\uace0 \uc788\uc73c\ub098, \ub098\ub178\uad6c\uc870 \uc9c0\uc9c8 \uc6b4\ubc18\uccb4(NLC)\ub294 13.04%\uc758 \ub354 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc744 \ubcf4\uc774\uba70 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc751\uc6a9 \ubd84\uc57c\ub294 \uc5f0\uad6c \ubc0f \uce58\ub8cc \ubd84\uc57c\ub85c \ub098\ub258\uba70, \ubd84\uc790 \uc720\ud615\ubcc4\ub85c\ub294 mRNA \ud398\uc774\ub85c\ub4dc\uac00 \uc804\uccb4 \uc218\uc775\uc758 54.60%\ub97c \ucc28\uc9c0\ud558\uba70 \ud604\uc7ac \uc751\uc6a9 \ubd84\uc57c\ub97c \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 siRNA\ub294 11.35%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \ubd84\uc790 \uc720\ud615\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\ub85c\ub294 \uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5, CDMO, \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00 \ub4f1\uc774 \uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 CDMO \ud22c\uc790 \ubc0f \uc815\ubd80 \uc9c0\uc6d0 \uc815\ucc45\uc5d0 \ud798\uc785\uc5b4 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 13.78%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \uae30\ub85d\ud558\uba70 \uae09\uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ubd81\ubbf8, \uc720\ub7fd, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8 \uc9c0\uc5ed\ub3c4 \uc2dc\uc7a5\uc758 \uc911\uc694\ud55c \ubd80\ubd84\uc744 \ucc28\uc9c0\ud569\ub2c8\ub2e4.<\/p>\n<p>\uae30\uc220\uc801 \ud601\uc2e0 \uce21\uba74\uc5d0\uc11c\ub294 AI \ud50c\ub7ab\ud3fc\uc774 \uac04 \uc774\uc678\uc758 \uc7a5\uae30\uc5d0\ub3c4 \uc57d\ubb3c\uc744 \uc804\ub2ec\ud560 \uc218 \uc788\ub294 \ud45c\uc801 \uc0dd\uccb4 \ubd84\ud3ec \ud504\ub85c\ud30c\uc77c\uc744 \uac00\uc9c4 \uc774\uc628\ud654 \uc9c0\uc9c8\uc744 \uc124\uacc4\ud558\uc5ec \uc784\uc0c1\uc801 \uac00\ub2a5\uc131\uc744 \ud655\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \ub9c8\uc774\ud06c\ub85c \uc720\uccb4 \uae30\ubc18 \uc5f0\uc18d \uc81c\uc870 \ubc29\uc2dd\uc740 \ubc30\uce58 \uc77c\uad00\uc131 \ud5a5\uc0c1, \uc6a9\ub9e4 \uc0ac\uc6a9\ub7c9 \uac10\uc18c, \uc0dd\uc0b0 \uc8fc\uae30 \ub2e8\ucd95\uc744 \ud1b5\ud574 \uc2e0\uc18d\ud55c \uc784\uc0c1 \uacf5\uae09\uc744 \uc9c0\uc6d0\ud558\uba70 \uac00\uc7a5 \ud601\uc2e0\uc801\uc778 \uc81c\uc870 \uae30\uc220\ub85c \ud3c9\uac00\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd\uc740 Merck KGaA, Croda International plc (Avanti Polar Lipids), Evonik Industries AG, Moderna Inc., Pfizer Inc., BioNTech SE \ub4f1 \ub2e4\uc218\uc758 \uae00\ub85c\ubc8c \uae30\uc5c5\ub4e4\uc774 \ucc38\uc5ec\ud558\uace0 \uc788\uc73c\uba70, \uc2dc\uc7a5 \uc9d1\uc911\ub3c4 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d, \uc8fc\uc694 \uae30\uc5c5 \ud504\ub85c\ud544\uc774 \ubcf4\uace0\uc11c\uc5d0 \ud3ec\ud568\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uaddc\uc81c \ud658\uacbd\uacfc \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d(\uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611, \uad6c\ub9e4\uc790 \ubc0f \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825, \ub300\uccb4\uc7ac\uc758 \uc704\ud611, \uacbd\uc7c1 \uac15\ub3c4)\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uad6c\uc870\uc801 \ud2b9\uc131\uc744 \uc2ec\uce35\uc801\uc73c\ub85c \ub2e4\ub8f9\ub2c8\ub2e4. \uc804\ubc18\uc801\uc73c\ub85c \uc9c0\uc9c8 \ub098\ub178\uc785\uc790 \uc2dc\uc7a5\uc740 \ubbf8\ucda9\uc871 \uc218\uc694\uc640 \uc0c8\ub85c\uc6b4 \uae30\ud68c\ub97c \ubc14\ud0d5\uc73c\ub85c \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc774 \uae30\ub300\ub429\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-53133","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/53133"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=53133"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/53133\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=53133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=53133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=53133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}